DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 175 mcg recall — FDA D-260-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
Monthly breakdown
2013 recalls by month
Select a month to review the recall records reported during that period.
2013 recalls — page 40
Records are ordered by the best available source date.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 137 mcg recall — FDA D-258-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 112 mcg recall — FDA D-256-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 50 mcg recall — FDA D-252-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 100 mcg recall — FDA D-255-2013
Chemical contamination: emission of strong odor after package was opened..
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 25 mcg recall — FDA D-251-2013
Chemical contamination: emission of strong odor after package was opened..
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 125 mcg recall — FDA D-257-2013
Chemical contamination: emission of strong odor after package was opened
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Precision Dose Children's Acetaminophen Oral Suspension, 650 mg/20.3 mL unit dose cup recall — FDA D-250-2013
Labeling: Not Elsewhere Classified: This unit dose product is being recalled because the product's name includes the word "Children's" which is misleading since the 650 mg dose of…
Class IIFDA: TerminatedPrecision Dose Inc.
DrugApr 24, 2013
The Menz Club Blue Male Enhancement Pill, bulk product, by The Menz Club, Ridgeland, MS recall — FDA D-266-2013
Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction,…
Class IFDA: OngoingThe Menz Club, LLC
DrugApr 24, 2013
Copaxone recall — FDA D-249-2013
Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to…
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 88 mcg recall — FDA D-254-2013
Chemical contamination: emission of strong odor after package was opened..
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 150 mcg recall — FDA D-259-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
DrugApr 24, 2013
Lupin Pharmaceuticals Suprax recall — FDA D-264-2013
Discoloration; Product may not meet specifications for color description once reconstituted.
Class IIIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugApr 24, 2013
Levoxyl (levothyroxine sodium) tablets, USP 75 mcg recall — FDA D-253-2013
Chemical contamination: emission of strong odor after package was opened.
Class IIFDA: CompletedPfizer Inc.
DrugApr 17, 2013
Gsms LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP, 20 mg/25 mg, 100 (NDC 60429-046-01) recall — FDA D-244-2013
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer
Class IIFDA: TerminatedGsms
DrugApr 17, 2013
Portia recall — FDA D-245-2013
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Class IIIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 17, 2013
Cefdinir for Oral Suspension, 125 mg/5 mL recall — FDA D-247-2013
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 17, 2013
Jolessa recall — FDA D-246-2013
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Class IIIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 10, 2013
Ferring Pharmaceuticals TEV-TROPIN (somatropin (rDNA origin) for injection) 5 mg (15 IU) recall — FDA D-240-2013
Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A
Class IIIFDA: TerminatedFerring Pharmaceuticals Inc.
DrugApr 10, 2013
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle recall — FDA D-238-2013
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Class IIIFDA: TerminatedDr. Reddy'S Laboratories
DrugApr 10, 2013
KETOCONAZOLE Fougera Ketoconazole Cream 2%, 15g tube recall — FDA D-241-2013
Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant…
Class IIIFDA: TerminatedFougera Pharmaceuticals Inc.
DrugApr 10, 2013
Palmer Natural Products Piracetam & Choline, 390mg Piracetam 104mg Choline Capsules, a) 30 recall — FDA D-233-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
DrugApr 10, 2013
Teva Pharmaceuticals USA CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets recall — FDA D-237-2013
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugApr 10, 2013
Palmer Natural Products BoostYourGrade.com, Piracetam 390mg Choline 104mg capsules, 250 recall — FDA D-235-2013
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Class IIFDA: TerminatedPalmer Natural Products
About the 2013 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.